Manufacturer:
AbbVie
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Approved Indication:
treatment of exocrine pancreatic insufficiency in adult and pediatric patients
Conditions:
- Exocrine Pancreatic Insufficiency
Therapeutic Area:
- Gastroenterology